Filter
2969
Filtered Results: 2969
Text search:
drug
market
Featured
Recommendations
260
New Publications
817
Language
Document type
No document type
1707
Studies & Reports
507
Guidelines
390
Manuals
141
Strategic & Response Plan
119
Training Material
39
Fact sheets
39
Situation Updates
10
Resource Platforms
8
Infographics
6
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
196
Global
122
Kenya
99
Uganda
82
Ethiopia
81
Nigeria
67
South Africa
65
Western and Central Europe
60
Ghana
51
Sierra Leone
49
Bangladesh
48
Liberia
48
Malawi
47
Tanzania
47
Nepal
46
Myanmar / Burma
46
Zambia
43
Rwanda
38
Africa
37
Latin America and the Carribbean
37
Namibia
34
South–East Asia Region
31
Philippines
30
Zimbabwe
27
Ukraine
25
Eastern Europe
22
Lesotho
21
Cambodia
21
Congo, Democratic Republic of
21
Indonesia
19
Syria
18
Asia
18
Botswana
18
Russia
15
Senegal
12
Mozambique
12
Eswatini/ Swaziland
11
Burkina Faso
10
Venezuela
10
East and Southern Africa
10
Brazil
10
USA
9
Eastern Europe and Central Asia
9
Thailand
8
Cameroon
8
Albania
8
Guinea
8
West and Central Africa
8
Middle East and North Africa
8
Georgia
8
South Sudan
8
Haiti
7
Germany
7
Laos
6
Vietnam
6
Sudan
6
Tajikistan
5
Colombia
5
China
5
North America
5
Timor Leste/ East Timor
4
Mexico
4
Western Pacific Region
4
Lebanon
4
Sri Lanka
4
Central African Republic
4
Libya
4
Iraq
4
North Macedonia
3
Benin
3
Iran
3
Peru
3
Jordan
3
Paraguay
3
Papua New Guinea
3
Moldova
3
Bhutan
3
Somalia
3
Pakistan
3
Chile
2
Fiji
2
Kyrgyzstan
2
Afghanistan
2
Morocco
2
Hungary
2
Tunisia
2
Argentina
2
Yemen
2
Palestine
2
Poland
2
Mali
2
North Korea
1
El Salvador
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Estonia
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Italy
1
Armenia
1
Dominican Republic
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Bolivia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Greece
1
Honduras
1
Angola
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1217
Clinical Guidelines
244
Public Health
152
Women & Child Health
89
Key Resources
88
Pharmacy & Technologies
48
Capacity Building
35
Toolboxes
HIV
302
Mental Health
292
TB
191
AMR
177
Pharmacy
142
COVID-19
116
NTDs
100
NCDs
72
Caregiver
51
Malaria
51
Planetary Health
40
Rapid Response
38
Conflict
38
Ebola & Marburg
37
Global Health Education
36
Refugee
35
Health Financing Toolbox
33
Disability
29
Natural Hazards
13
Cholera
12
Specific Hazards
10
Social Ethics
7
Polio
7
2.0 Rapid Response
5
Zika
5
Tuberculosis cases, TB deaths
Strategy for Increasing the use of Modern Contraceptives in Nigeria
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
The document outlines essential steps and provides guidance to countries on the adoption and deployment of c-IPTp so that it is integrated into the existing health system. It draws upon best practices and lessons learned from pilot implementation experiences in eight African countries and targets st...
Report of a virtual meeting 21–23 June 2022
Preferred product characteristics and clinical development considerations
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
